Furiex Pharmaceuticals, Inc.

Release Summary

Furiex Receives Qualified Infectious Disease Product and Fast Track Designations from the U.S. Food and Drug Administration for Avarofloxacin (JNJ-Q2)

Furiex Pharmaceuticals, Inc.